Fundraising Fox
Ligandal
6 known investors
Find your way into Ligandal
Sign up to see every warm intro you have to Ligandal
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ligandal team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
Founders & leadership
AW
Andre WatsonFounder, Chairman & CEOAndre Watson is Founder and CEO of Ligandal, a biotechnology company developing AI-driven targeting peptides and precision delivery platforms for therapeutics. He holds a background in Biomedical Engineering with a focus on biomaterials science and gene delivery, and holds multiple patents in drug delivery, gene therapy, and protein engineering approaches.30 Under 30 2021
Investors · 6
Flucas Ventureslisted by Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
How we know: the VCSheet dataset · Not right? Tell us
__Twitter.png)
Hemisphere Ventures LLClisted by Hemisphere Ventures LLCMckinney
How we know: Hemisphere Ventures LLC's portfolio page · Not right? Tell us
Learn CapitalreportedAustin · $100K – $20M
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Ligandal do?
- Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
- Who founded Ligandal?
- Ligandal was founded by Andre Watson.
- Who are Ligandal's investors?
- Ligandal's investors include Flucas Ventures, Gaingels, Hemisphere Ventures LLC, Machina Ventures, Sommet AB, Learn Capital.